CFM
APYX icon

Catalyst Funds Management’s Apyx Medical APYX Stock Holding History

Catalyst Funds Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,072
Closed -$88.8K – 663
2026
Q1 		$88.8K Buy
+24,072
New +$90K 0.02% 496

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Catalyst Funds Management's APYX Position: Q2 2026 in Review

Catalyst Funds Management sold out of Apyx Medical (APYX) in Q2 2026, closing a stake of 24,072 shares — an estimated $88.8K sold.

Catalyst Funds Management first reported a position in APYX in Q1 2026 and held it in 1 quarter. The position peaked at $88.8K in Q1 2026. 68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Catalyst Funds Management reported no remaining Apyx Medical position as of Q2 2026 after selling out during the quarter.
  • Catalyst Funds Management sold 24,072 Apyx Medical shares in Q2 2026, an estimated $88.8K.
  • Catalyst Funds Management first reported a position in Apyx Medical in Q1 2026 and held it in 1 quarter.
  • Catalyst Funds Management's Apyx Medical position peaked at $88.8K in Q1 2026.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.